Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. junior Avg
|
New words:
adjuvant, Africa, Amgen, Biomedical, biopharmaceutical, candidate, chemotherapy, Cirqle, Colorectal, conditionally, COVID, denosumab, developmental, discretionary, economy, energy, Esophageal, Hepatocellular, high, hyperinflationary, ipilimumab, Malignant, melanoma, Mesothelioma, mutually, myeloma, negotiate, partly, Perjeta, pertuzumab, Pleural, prepayment, referencing, Shanghai, solid, South, Squibb, Taiwan, unresectable, Yervoy
Filing tables
Filing exhibits
Related press release
Associated OGN transcripts
OGN similar filings
Filing view
External links